BEAM THERAPEUTICS INC (BEAM)
US07373V1052 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to BEAM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 51. This target is 111.62% above the current price.
BEAM was analyzed by 21 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about BEAM.
In the previous month the buy percentage consensus was at a similar level.
BEAM was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-27 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-02-28 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-29 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-12-15 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-12-08 | Jefferies | Downgrade | Buy -> Hold |
| 2023-10-17 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-29 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-09 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-08-09 | Citigroup | Maintains | Buy -> Buy |
| 2023-05-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-11 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-11 | Citigroup | Maintains | Buy -> Buy |
| 2023-03-21 | Bernstein | Initiate | Market Perform |
| 2023-03-01 | Wells Fargo | Maintains | Overweight |
| 2023-02-01 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-01-23 | SVB Leerink | Maintains | Outperform |
| 2022-12-20 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2022-12-13 | Citigroup | Initiate | Buy |
| 2022-11-08 | Credit Suisse | Maintains | Neutral |
| 2022-11-07 | SVB Leerink | Maintains | Outperform |
| 2022-08-10 | SVB Leerink | Maintains | Outperform |
| 2022-08-10 | Barclays | Maintains | Equal-Weight |
| 2022-06-17 | BMO Capital | Initiate | Market Perform |
| 2022-05-09 | SVB Leerink | Maintains | Outperform |
| 2022-04-28 | Credit Suisse | Initiate | Neutral |
| 2022-01-10 | SVB Leerink | Maintains | Outperform |
| 2022-01-05 | Guggenheim | Initiate | Buy |